Biotech

All Articles

OS Treatments refiles $6M IPO to money HER2 medication, preclinical ADCs

.Operating system Therapies will detail on the NYSE American inventory exchange this morning through...

ALX's waning CD47 feedback fee sends out stock spiraling down

.ALX Oncology's stage 2 gastric cancer response fee has compromised. After finding its own CD47 bloc...

Ionis axes eye health condition coming from targets of Roche-partnered possibility after information disappoint

.An Additional of Ionis Pharmaceuticals' key midphase readouts has fallen short of expectations, tri...

Biogen's chief executive officer said no high-risk handle 2023. He prepares to be strong

.While Biogen's pharma peers are looking for late-stage resources along with little bit of risk, chi...

Instil refills pipeline in $2B biobucks manage ImmunOnco

.Instil Bio has actually been actually a biotech trying to find a pipe after it junked its lead poss...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually returned liberties to a very early Alzheimer's condition plan to Denali Therapi...

Takeda taps new head people oncology business-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of considerable leadership hirings, shooting...

Vertex, hammered through AATD once more, drops 2 possessions on discard stack

.Vertex's attempt to manage an unusual genetic condition has actually hit one more trouble. The biot...

Vir increases 3 T-cell engagers from Sanofi, lays off 25% of personnel

.Vir Biotechnology's second-quarter revenues file had not been except significant headlines. The pro...

Galapagos stops briefly CAR-T cell treatment hearing over Parkinsonism scenario

.Galapagos has actually stopped application in a test of a BCMA-directed CAR-T tissue treatment, pus...